InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,666.40
(
0.13%
)
Dow Jones
39,308.00
(
0.00%
)
Brent Oil
87.00
(
-0.38%
)
Bitcoin
55,327.32
(
-2.90%
)
Post# of 252487
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: None

Thursday, 10/18/2018 10:31:50 AM

Thursday, October 18, 2018 10:31:50 AM

Post# of 252487
Waltham's Morphic Therapeutic inks $100M deal with AbbVie
https://www.bizjournals.com/boston/news/2018/10/18/walthams-morphic-therapeutic-inks-100m-deal-with.html

A preclinical Waltham biotech company is hoping to launch its first clinical trial of a fibrosis treatment next year after signing a $100 million collaboration agreement with AbbVie this week.

Morphic Therapeutic is partnering with AbbVie to develop drugs that could halt organ-harming tissue buildup resulting from chronic inflammation in the lungs or liver. AbbVie (NYSE: ABBV) will pay $100 million up front for exclusive licensing rights to any drugs developed, and will be responsible for global development and commercialization.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up